Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2024)

Catheter Precision (VTAK) Capital Expenditures Growth (3y) (2020 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 182.65 Bn 175.35 Bn 6.27 Bn 1.64%
2 Stryker 128.95 Bn 126.08 Bn 3.81 Bn 8.49%
3 Medtronic 108.30 Bn 99.08 Bn 6.41 Bn 8.89%
4 Boston Scientific 68.31 Bn 66.85 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 48.19 Bn 44.52 Bn 1.29 Bn 1.81%
6 Dexcom 28.33 Bn 27.21 Bn 750.30 Mn 0.84%
7 GE HealthCare Technologies 28.02 Bn 25.74 Bn 1.98 Bn 7.57%
8 Smith & Nephew 26.97 Bn 26.39 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn 2.15%
10 Catheter Precision 613,931.84 213,931.84 390,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2024 -9.03%
Dec 31, 2023 77.58%
Sep 30, 2023 -64.84%
Jun 30, 2023 -1.61%
Mar 31, 2023 9.74%
Dec 31, 2022 -29.25%
Dec 31, 2021 -27.18%
Sep 30, 2021 -35.35%
Jun 30, 2021 -12.09%
Mar 31, 2021 -44.97%
Dec 31, 2020 -26.38%